Critically, we observed strong synergy between MEK and CENPE inhibition as well as MEK and RRM1 inhibition in three different pancreatic cancer cells at several different drug concentrations by measuring combination index (CI <1)31,32 (Fig. 2e, f). The gene discussed is RRM1; the disease is familial pancreatic carcinoma.